- Start
- Resistance to Ibritumomab in Lymphoma
Resistance to Ibritumomab in Lymphoma
Angebote / Angebote:
This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.
Lieferbar in ca. 20-45 Arbeitstagen